[1]
Paul, R.S. et al. 2026. Febuxostat and Renal Outcomes in Stage 3-4 CKD Patients with Asymptomatic Hyperuricemia: A Prospective Observational Study. Journal of Rangpur Medical College. 11, 1 (May 2026), 3–8. DOI:https://doi.org/10.3329/jrpmc.v11i1.89919.